Spelling suggestions: "subject:"dendritic cells"" "subject:"dendritica cells""
21 |
Investigating the Factors that Govern the Induction of an In vivo Cytotoxic T-lymphocyte Response against a Tissue-borne AntigenDissanayake, Dilan 28 February 2013 (has links)
In addition to their activity against intracellular pathogens, it is now clear that CD8+ T-lymphocytes also mediate anti-tissue responses. In order to manipulate these responses in the setting of tumor immunity or autoimmunity, it is necessary that we understand the parameters that promote CD8+ activation. In the first section of this thesis, a transgenic mouse model was used to explore the effectiveness of peptide/adjuvant-based and dendritic cell (DC)-based vaccination techniques at eliciting CD8-mediated anti-pancreatic responses. It was found that, while peptide vaccines were unable to stimulate autoimmunity, the transfer of DCs promoted autoimmune diabetes in a manner that was dependent upon the toll-like receptor (TLR)-based maturation of the DCs. Furthermore, the diabetes induction was dependent upon the engagement of the immunodominant CD8+ population and a second T-cell specificity, indicating that polyclonal responses may be required for effective tissue destruction. In the second section of this thesis, I explored the requirements for CD28-signaling during the activation of naïve self-reactive CD8+ T-cells. The transfer of mature DCs was insufficient to promote diabetes in CD28-deficient animals, whereas infection with lymphocytic choriomeningitis virus could induce diabetes in the same animals. Anti-tissue responses were further explored in tumor-bearing mice following DC transfer and demonstrated that a critical determinant of the induction of anti-tissue immunity in the absence of CD28-derived costimulatory signals, was the persistence of antigen presentation. In the final section of this thesis, I explored the role of nuclear factor kappa B 1 (NF-κB1) in DC maturation using the DC transfer model described above. Surprisingly, NF-κB1-deficient DCs were capable of inducing diabetes without the need for external stimulation. Furthermore, the absence of NF-κB1 in unstimulated DCs was associated with dysregulated production of tumor necrosis factor alpha (TNF-α), and this cytokine was required for the proper upregulation of the cytotoxic effector molecule granzyme B in CD8+ T-cells that infiltrated the pancreatic islets. This work therefore presents a novel model of autoimmune tissue destruction, in which defined genes and pathways that contribute to DC-T-cell interactions can be explored in an in vivo non-TCR transgenic setting.
|
22 |
Human dendritic cells and hepatitis C VirusLandi, Abdolamir 12 January 2010 (has links)
Dendritic cells (DCs) constitute a large family of immune cells with a dendritic morphology and a critical role in all aspects of an immune response and immune regulation, from immunogenicity to tolerance. One of the important characteristic of DCs is maturation, during which DCs undergo significant changes in their phenotypic and functional properties and change from phagocytic cells to highly efficient antigen presenting cells (APCs). Dendritic cells have recently been at the centre of attention as a promising tool in treatment or control of cancer and infectious diseases. Accordingly, DCs have been generated, matured, and loaded with tumor-associated or microbial antigens ex vivo, to be subsequently used as therapeutic tools or vaccine carriers.<p>
Hepatitis C virus (HCV) is a hepatotropic virus, which infects the liver in humans and results in a chronic infection in most cases. The persistent infection of the liver eventually results in cirrhosis and/or hepatocellular carcinoma in 15-20 years. Chronic hepatitis C (CHC) has recently become a serious health concern and the leading cause of liver transplantation. The mechanism of persistence of the virus is not clear yet, but as a Th1-type immune response is strongly correlated with elimination of HCV in vivo, it is evident that insufficient cellular immunity is a contributing factor. Non-cytopathic viruses such as HCV may infect immune cells to modify and evade a protective immune response. Dendritic cells, which are the most potent APCs, and uniquely capable of initiating a primary immune response, have been considered as a target for HCV. Inhibition of DC maturation by HCV has been suggested as a potential contributing factor in immune evasion; however, this issue remains controversial as many contradictory results have been reported.<p>
To investigate this contention, we initially planned to evaluate the effects of HCV on DCs of CHC patients; however, due to limited access to patients blood, we instead elected to examine the effects of HCV genes products on in vitro generated DCs from healthy volunteers. Specific attention was paid to the generation, maturation, and transfection of DCs in vitro, as variability in procedures might have been responsible for the controversial reports. Viral vectors have generally been used to transfect DCs; however, a vector and HCV genes might have synergistic effects on DC maturation. Thus, our first objective was to develop an efficient non-viral transfection method while retaining high viability of the DCs, as previous efforts in this regard resulted either in low efficiency or in low viability of DCs after transfection. In order to improve the viability of DCs after transfection, we established a new method for fast generation of monocyte-derived DCs (Mo-DCs) in two to three days. By performing a comprehensive study on transfection reagents, electroporation, and nucleofection with DNA or in vitro transcribed (IVT) RNA, we successfully established a new, highly efficient non-viral method for transfection of DCs with long-term viability. This method is based on the use of the X1 program of a nucleofection device with IVT RNA and results in high transfection efficiency of 93%, with 75% viability of DCs 72 h after transfection.<p>
Subsequently, we performed a comprehensive study on the effects of different maturation methods on the phenotype, function and gene expression profile of DCs. Three commonly used treatments, TNF-á, LPS and a maturation cocktail (MC) consisting of IL-1â, IL-6, TNF-á, and prostaglandin E2 (PGE2) were compared. Our results showed that there is a significant difference in the level of maturity between these treatments, and MC generated more functionally competent mDCs than TNF-á or LPS. In addition, MC induced Th1-promoting changes in the transcriptional profile of mDCs. This observation was important, as the presence of PGE2 in MC was previously challenged based on the potential induction of Th2-biased immune responses. However, our results suggest retaining PGE2 in the cocktail because of the fact that MC generated highly competent and functional mDCs with a Th1-promoting transcriptional profile.
Finally, Mo-DCs were transfected with IVT HCV RNAs, individually or in combination. While HCV genes had no inhibitory effect on DC maturation, transfection of DCs with IVT core RNA appeared to result in changes compatible with maturation. To investigate this in more detail, the transcriptional profiles of DCs transfected with IVT core, NS3 or green fluorescent protein (GFP) RNA were examined using a DC-specific membrane array. Of the 288 genes on the array, 46 genes were distinctively up- or down-regulated by transfection with IVT core RNA in comparison to NS3 or GFP RNA treatments, 42 of which are involved in DC maturation. The effects of core on maturation of DCs were further confirmed by a significant increase in surface expression of CD83 and HLA-DR, a reduction of phagocytosis, as well as an increase in proliferation and IFN-ã secretion by T cells in a mixed lymphocyte reaction assay. These results show that HCV core does not have an inhibitory effect on human DC maturation, but could be a target for the immune system.<p>
The use of a non-viral method of transfection combined with confirmed transcriptional profiles of DCs in this study may make these results conclusive for in vitro generated DCs from healthy volunteers. However, further investigations are required to confirm the effects on DCs from CHC patients.
|
23 |
Sublethal iron overload can alter the morphology and function of dendritic cells which may predispose to gram-negative infection in beta-thalassemiaDee, Cathleen Michelle Ang, 李明芳 January 2014 (has links)
abstract / Paediatrics and Adolescent Medicine / Doctoral / Doctor of Philosophy
|
24 |
Dendritic cell-based therapy of experimental autoimmune uveoretinitisKlaska, Izabela January 2013 (has links)
Recently, there has been considerable interest in developing specific cell-based immunotherapies using dendritic cells (DCs). Here the mechanisms underlying the tolerogenic properties of DCs in the suppression of experimental autoimmune uveoretinitis (EAU), the mouse model of human sight threatening autoimmune uveitis, were examined. Immature DCs have the ability to promote immune tolerance to self antigens and to prevent the development of autoimmune disorders including EAU. However there is a risk that immature DCs placed in the inflammatory environment would undergo maturation and instead of tolerance promote immunity. Therefore much effort has been directed to develop protocols that stabilize the tolerogenic DC properties which would ultimately ensure safety and effectiveness of DC-based vaccines. Previous work demonstrated that activation of DCs with lipopolysaccharide (LPS) increases the ability of these cells to prevent EAU. Here, it was demonstrated that LPS promotes the activation of both TRIF and MyD88 signalling pathways in DCs which after 24 h LPS treatment secreted a significant amount of IL-10, IFN-β, IL-1β, IL-6 and TNF-α while the level of secreted IL-12 is low. It was further shown that LPSinduced enhancement of the tolerogenic properties of DCs correlates with the state of endotoxin tolerance in the DCs, rendering them refractory to further stimulation. It was hypothesised that the LPS-induced enhancement of DC tolerogenicity is due to the reduced expression of the TLR4, which subsequently disables several signalling pathways and prevent DCs from initiating adaptive T cell immunity. In summary, the presented data provides valuable insights into the mechanisms involved in the suppression of autoimmune uveitis using a DC-based therapy.
|
25 |
Functional comparison of cord and adult blood-derived dendritic cellsWong, On-hang., 黃安恆. January 2004 (has links)
published_or_final_version / abstract / toc / Paediatrics and Adolescent Medicine / Master / Master of Philosophy
|
26 |
The Role of Dendritic Cells in Tolerance InductionFarquhar, Claire A. January 2008 (has links)
No description available.
|
27 |
Dendritic cell function in HIV diseaseWhelan, Kathryn Theresa January 2003 (has links)
Human immunodeficiency virus (HIV) infection is a worldwide epidemic where infected individuals usually develop acquired immunodeficiency syndrome (AIDS). HIV is primarily spread by sexual transmission across mucosal tissue where dendritic cells (DC) reside. DC regulate immune responses through their unique ability to capture antigen, migrate to lymphoid tissue, and activate naive T cells. In this Thesis, we have investigated whether HIV influences the migration of DC, thereby influencing their capacity to regulate immune function and facilitate transport of HIV to T cell rich lymphoid tissue. Transmigration assays demonstrated that the predominant HIV strain during primary infection, R5 HIV-1, was chemotactic for immature DC (iDC). Addition of soluble CD4 enhanced iDC migration to R5 HIV, presumably by binding to R5 HIV and altering the conformation to enhance binding to CCR5. Our results suggested that iDC migrated specifically to R5 and not X4 HIV gp120, through interactions between the extracellular loop-2 (ECL-2) domain of CCR5 with the V3 loop region of R5 gp120. iDC prepared from HIV-infected subjects were shown to have impaired chemotaxis to inflammatory chemokines compared with iDC from healthy individuals. Furthermore, the level of inhibition appeared to be proportional to the severity of disease progression in HIV infected subjects. Interestingly, chemotaxis of iDC from long-term non-progressor individuals was similar to normal individuals, whereas migration of iDC from typical progressors was greatly impaired. These differences did not appear to be related to the level of CCR5 expression or patient viral load. The protease inhibitor Indinavir used in antiretroviral therapy, limited DC trans-endothelial migration to chemokines, reduced DC-SIGN expression and increased CD83 on iDC. The results suggested that Indinavir inhibited proteases necessary for DC migration by adversely affecting interactions between DC-SIGN, VLA-4 and VLA-5 and ligands on the endothelium and underlying fibronectin matrix. A novel method has been successfully developed for amplifying rare HIV-specific CDS cells using DC transfected with HLA antigens matching HIV-infected subjects. This has enabled us to amplify HIV-specific CDS T cells by 10- to 60-fold. This may help us to clone and characterise HIV-specific CDS T cells from highly exposed persistently seronegative (HEPS) individuals. In summary, the results in this Thesis demonstrate that R5 HIV mimics chemokines to subvert the natural trafficking of DC. Indeed, we have shown that DC from typical progressors have severely impaired migration. This may have serious consequences on DC immunoregulation, compromising the immune function of these infected individuals.
|
28 |
Investigating the Factors that Govern the Induction of an In vivo Cytotoxic T-lymphocyte Response against a Tissue-borne AntigenDissanayake, Dilan 28 February 2013 (has links)
In addition to their activity against intracellular pathogens, it is now clear that CD8+ T-lymphocytes also mediate anti-tissue responses. In order to manipulate these responses in the setting of tumor immunity or autoimmunity, it is necessary that we understand the parameters that promote CD8+ activation. In the first section of this thesis, a transgenic mouse model was used to explore the effectiveness of peptide/adjuvant-based and dendritic cell (DC)-based vaccination techniques at eliciting CD8-mediated anti-pancreatic responses. It was found that, while peptide vaccines were unable to stimulate autoimmunity, the transfer of DCs promoted autoimmune diabetes in a manner that was dependent upon the toll-like receptor (TLR)-based maturation of the DCs. Furthermore, the diabetes induction was dependent upon the engagement of the immunodominant CD8+ population and a second T-cell specificity, indicating that polyclonal responses may be required for effective tissue destruction. In the second section of this thesis, I explored the requirements for CD28-signaling during the activation of naïve self-reactive CD8+ T-cells. The transfer of mature DCs was insufficient to promote diabetes in CD28-deficient animals, whereas infection with lymphocytic choriomeningitis virus could induce diabetes in the same animals. Anti-tissue responses were further explored in tumor-bearing mice following DC transfer and demonstrated that a critical determinant of the induction of anti-tissue immunity in the absence of CD28-derived costimulatory signals, was the persistence of antigen presentation. In the final section of this thesis, I explored the role of nuclear factor kappa B 1 (NF-κB1) in DC maturation using the DC transfer model described above. Surprisingly, NF-κB1-deficient DCs were capable of inducing diabetes without the need for external stimulation. Furthermore, the absence of NF-κB1 in unstimulated DCs was associated with dysregulated production of tumor necrosis factor alpha (TNF-α), and this cytokine was required for the proper upregulation of the cytotoxic effector molecule granzyme B in CD8+ T-cells that infiltrated the pancreatic islets. This work therefore presents a novel model of autoimmune tissue destruction, in which defined genes and pathways that contribute to DC-T-cell interactions can be explored in an in vivo non-TCR transgenic setting.
|
29 |
The role of peripheral dendritic cells in systemic lupus erythematosusJin, Ou, January 2007 (has links)
Thesis (Ph. D.)--University of Hong Kong, 2008. / Also available in print.
|
30 |
The role of peripheral dendritic cells in systemic lupus erythematosus /Jin, Ou, January 2007 (has links)
Thesis (Ph. D.)--University of Hong Kong, 2008. / Also available online.
|
Page generated in 0.3302 seconds